摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-5-chlorothiophene-2-carboxylic acid | 89499-41-2

中文名称
——
中文别名
——
英文名称
4-amino-5-chlorothiophene-2-carboxylic acid
英文别名
2-Thiophenecarboxylic acid, 4-amino-5-chloro-
4-amino-5-chlorothiophene-2-carboxylic acid化学式
CAS
89499-41-2
化学式
C5H4ClNO2S
mdl
——
分子量
177.611
InChiKey
AZXFRUSWZQOXLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    197 °C
  • 沸点:
    408.6±45.0 °C(Predicted)
  • 密度:
    1.680±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    91.6
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:669d4c1f2cb1b1f44ce36d09bf06dbf2
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-[4-[(5S)-5-(氨甲基)-2-羰基-3-唑烷基]苯基]-3-吗啡啉酮4-amino-5-chlorothiophene-2-carboxylic acid1-羟基苯并三唑1-(3-二甲基氨基丙基)-3-乙基碳二亚胺N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 4-Amino-5-chloro-thiophene-2-carboxylic acid {(S)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-amide
    参考文献:
    名称:
    Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939):  An Oral, Direct Factor Xa Inhibitor
    摘要:
    Despite recent progress in antithrombotic therapy, there is still an unmet medical need for safe and orally available anticoagulants. The coagulation enzyme Factor Xa (FXa) is a particularly promising target, and recent efforts in this field have focused on the identification of small-molecule inhibitors with good oral bioavailability. We identified oxazolidinone derivatives as a new class of potent FXa inhibitors. Lead optimization led to the discovery of BAY 59-7939 (5), a highly potent and selective, direct FXa inhibitor with excellent in vivo antithrombotic activity. The X-ray crystal structure of 5 in complex with human FXa clarified the binding mode and the stringent requirements for high affinity. The interaction of the neutral ligand chlorothiophene in the S1 subsite allows for the combination of good oral bioavailability and high potency for nonbasic 5. Compound 5 is currently under clinical development for the prevention and treatment of thromboembolic diseases.
    DOI:
    10.1021/jm050101d
  • 作为产物:
    描述:
    参考文献:
    名称:
    GOLDFARB, YA. L.;BULGAKOVA, V. N.;FABRICHNYJ, B. P., XIMIYA GETEROTSIKL. SOEDIN., 1983, N 12, 1626-1629
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • INSECTICIDAL COMPOUNDS
    申请人:Jung Pierre
    公开号:US20090192175A1
    公开(公告)日:2009-07-30
    Novel heteroaromatic compounds of formula (I): wherein A 1 , A 2 , A 3 , R 1 , R 2 , G 1 , G 2 , Q 1 and Q 2 are as defined in claim 1 ; or salts or N-oxides thereof. Furthermore, the present invention relates to processes for preparing compounds of formula (I), to insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control insect, acarine, mollusc and nematode pests.
    式(I)的新异杂芳化合物:其中A1、A2、A3、R1、R2、G1、G2、Q1和Q2如权利要求1所定义;或其盐或N-氧化物。此外,本发明涉及制备式(I)化合物的方法,以及包含它们的杀虫剂、杀螨剂、杀软体动物剂和杀线虫剂组合物,以及使用它们来打击和控制昆虫、螨、软体动物和线虫害的方法。
  • Reductive acetylation of nitrocarboxylic acids of the thiophene and furan series or their esters
    作者:Ya. L. Gol'dfarb、V. N. Bulgakova、B. P. Fabrichnyi
    DOI:10.1007/bf00842830
    日期:1983.12
  • US8252936B2
    申请人:——
    公开号:US8252936B2
    公开(公告)日:2012-08-28
  • [EN] INSECTICIDAL COMPOUNDS<br/>[FR] COMPOSÉS INSECTICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2007128410A1
    公开(公告)日:2007-11-15
    [EN] Novel heteroaromatic compounds of formula (I): wherein A1, A2, A3, R1, R2, G1, G2, Q1 and Q2 are as defined in claim 1; or salts or N-oxides thereof. Furthermore, the present invention relates to processes for preparing compounds of formula (I), to insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control insect, acarine, mollusc and nematode pests.
    [FR] L'invention porte sur de nouveaux composés hétéroaromatiques de formule (I) dans laquelle: A1, A2, A3, R1, R2, G1, G2, Q1 et Q2 sont tels que définis dans la revendication 1; ou sur leurs sels ou N oxydes. L'invention porte également: sur le procédé de préparation lesdits composés; sur des compositions insecticides, acaricidesl, molluscicides et nématicides les comprenant; et sur des leurs procédés d'utilisation pour combattre et éradiquer les insectes, les acariens, les mollusques et les nématodes nuisibles.
  • Discovery of the Novel Antithrombotic Agent 5-Chloro-<i>N</i>-({(5<i>S</i>)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939):  An Oral, Direct Factor Xa Inhibitor
    作者:Susanne Roehrig、Alexander Straub、Jens Pohlmann、Thomas Lampe、Josef Pernerstorfer、Karl-Heinz Schlemmer、Peter Reinemer、Elisabeth Perzborn
    DOI:10.1021/jm050101d
    日期:2005.9.1
    Despite recent progress in antithrombotic therapy, there is still an unmet medical need for safe and orally available anticoagulants. The coagulation enzyme Factor Xa (FXa) is a particularly promising target, and recent efforts in this field have focused on the identification of small-molecule inhibitors with good oral bioavailability. We identified oxazolidinone derivatives as a new class of potent FXa inhibitors. Lead optimization led to the discovery of BAY 59-7939 (5), a highly potent and selective, direct FXa inhibitor with excellent in vivo antithrombotic activity. The X-ray crystal structure of 5 in complex with human FXa clarified the binding mode and the stringent requirements for high affinity. The interaction of the neutral ligand chlorothiophene in the S1 subsite allows for the combination of good oral bioavailability and high potency for nonbasic 5. Compound 5 is currently under clinical development for the prevention and treatment of thromboembolic diseases.
查看更多

同类化合物

阿罗洛尔 阿替卡因 阿克兰酯 锡烷,(5-己基-2-噻吩基)三甲基- 邻氨基噻吩(2盐酸) 辛基5-(1,3-二氧戊环-2-基)-2-噻吩羧酸酯 辛基4,6-二溴噻吩并[3,4-b]噻吩-2-羧酸酯 辛基2-甲基异巴豆酸酯 血管紧张素IIAT2受体激动剂 葡聚糖凝胶LH-20 苯螨噻 苯并[c]噻吩-1-羧酸,5-溴-4,5,6,7-四氢-3-(甲硫基)-4-羰基-,乙基酯 苯并[b]噻吩-2-胺 苯并[b]噻吩-2-胺 苯基-[5-(4,4,5,5-四甲基-[1,3,2]二氧杂硼烷-2-基)-噻吩-2-基亚甲基]-胺 苯基-(5-氯噻吩-2-基)甲醇 苯乙酸,-α--[(1-羰基-2-丙烯-1-基)氨基]- 苯乙酰胺,3,5-二氨基-a-羟基-2,4,6-三碘- 苯乙脒,2,6-二氯-a-羟基- 腈氨噻唑 聚(3-丁基噻吩-2,5-二基),REGIOREGULAR 硝呋肼 硅烷,(3-己基-2,5-噻吩二基)二[三甲基- 硅噻菌胺 盐酸阿罗洛尔 盐酸阿罗洛尔 盐酸多佐胺 甲酮,[5-(1-环己烯-1-基)-4-(2-噻嗯基)-1H-吡咯-3-基]-2-噻嗯基- 甲基5-甲酰基-4-甲基-2-噻吩羧酸酯 甲基5-乙氧基-3-羟基-2-噻吩羧酸酯 甲基5-乙基-3-肼基-2-噻吩羧酸酯 甲基5-(氯甲酰基)-2-噻吩羧酸酯 甲基5-(氯乙酰基)-2-噻吩羧酸酯 甲基5-(氨基甲基)噻吩-2-羧酸酯 甲基5-(4-甲氧基苯基)-2-噻吩羧酸酯 甲基5-(4-甲基苯基)-2-噻吩羧酸酯 甲基5-(1,3-二氧戊环-2-基)-2-噻吩羧酸酯 甲基4-硝基-2-噻吩羧酸酯 甲基4-氰基-5-(4,6-二氨基吡啶-2-基)偶氮-3-甲基噻吩-2-羧酸酯 甲基4-氨基-5-(甲硫基)-2-噻吩羧酸酯 甲基4-{[(2E)-2-(4-氰基苯亚甲基)肼基]磺酰}噻吩-3-羧酸酯 甲基4-(氯甲酰基)-3-噻吩羧酸酯 甲基4-(氨基磺酰基氨基)-3-噻吩羧酸酯 甲基3-甲酰氨基-4-甲基-2-噻吩羧酸酯 甲基3-氨基-5-异丙基-2-噻吩羧酸酯 甲基3-氨基-5-(4-溴苯基)-2-噻吩羧酸酯 甲基3-氨基-4-苯基-5-(三氟甲基)-2-噻吩羧酸酯 甲基3-氨基-4-氰基-5-甲基-2-噻吩羧酸酯 甲基3-氨基-4-丙基-2-噻吩羧酸酯 甲基3-[[(4-甲氧基苯基)亚甲基氨基]氨基磺酰基]噻吩-2-羧酸酯